MID1 and retinopathy of prematurity: In summary, the present pilot study in hyperglycemic and naive ROP/Os+ mice demonstrates that control of OS/Infl with currently available and relatively inexpensive and safe agents can modulate established GS, and DKD, decrease the sclerosis-prone phenotype in mice.